Literature DB >> 18440862

Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases.

Olav Lindqvist1, Birgit H Rasmussen, Anders Widmark.   

Abstract

Advanced prostate cancer with skeletal metastases entails significant symptoms from both treatment and the disease itself. Although the diagnosis is a common one, knowledge of the symptom experience late in the disease trajectory is limited. The aim of the present study was to describe the experience of physical symptoms in men with hormone refractory prostate cancer and skeletal metastases. Twenty men answered a quality of life questionnaire before participating in semi-structured interviews. The interviews were analyzed using qualitative description. Findings show that the dominant symptoms were lack of energy and pain. Interestingly when talking about lacking energy the men described three different variants; lack of mental energy or initiative, lack of strength and stamina, and tiredness or sleepiness. Also, three different types of pain were described; pain from skeletal metastases, a diffuse moving pain, and pain not directly caused by the prostate cancer. Though a majority of the men scored being dissatisfied with their sex life; in the interviews, this was not described as a major distress. The findings also showed that the men experienced different symptoms despite the same diagnosis, skeletal metastases, stage, and androgen deprivation treatment, and that these symptoms are not necessarily experienced as problems or causing distress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440862     DOI: 10.1016/j.ejon.2008.03.003

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  7 in total

Review 1.  Qualitative research into the symptom experiences of adult cancer patients after treatments: a systematic review and meta-synthesis.

Authors:  A E Bennion; A Molassiotis
Journal:  Support Care Cancer       Date:  2012-09-13       Impact factor: 3.603

2.  Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative exploration.

Authors:  Lauren Matheson; Jo Nayoan; Carol Rivas; Jo Brett; Penny Wright; Hugh Butcher; Paul Jordan; Anna Gavin; Adam Glaser; Malcolm Mason; Richard Wagland; Eila Watson
Journal:  Support Care Cancer       Date:  2020-07-06       Impact factor: 3.603

3.  Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis.

Authors:  Giandomenico Roviello; Daniele Generali
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

4.  Pain in castration-resistant prostate cancer with bone metastases: a qualitative study.

Authors:  Adam Gater; Linda Abetz-Webb; Clare Battersby; Bhash Parasuraman; Stuart McIntosh; Faith Nathan; Elisabeth C Piault
Journal:  Health Qual Life Outcomes       Date:  2011-10-12       Impact factor: 3.186

5.  Quality of life in men with metastatic prostate cancer in their final years before death - a retrospective analysis of prospective data.

Authors:  Maja Holm; Sandra Doveson; Olav Lindqvist; Agneta Wennman-Larsen; Per Fransson
Journal:  BMC Palliat Care       Date:  2018-12-03       Impact factor: 3.234

6.  PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study.

Authors:  A Rodríguez Antolín; L Martínez-Piñeiro; M E Jiménez Romero; J B García Ramos; D López Bellido; J Muñoz Del Toro; A García García-Porrero; F Gómez Veiga
Journal:  BMC Urol       Date:  2019-10-16       Impact factor: 2.264

Review 7.  Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.

Authors:  Ravi A Madan; Emmanuel S Antonarakis; Charles G Drake; Lawrence Fong; Evan Y Yu; Douglas G McNeel; Daniel W Lin; Nancy N Chang; Nadeem A Sheikh; James L Gulley
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.